Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation

Ethanol Extracts of Fresh Davallia formosana (WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation

The rhizome of Davallia formosana is commonly used to treat bone disease including bone fracture, arthritis, and osteoporosis in Chinese herbal medicine. Here, we report the effects of WL1101, the ethanol extracts of fresh rhizomes of Davallia formosana on ovariectomy-induced osteoporosis. In additi...

Full description

Bibliographic Details
Main Authors:	Tzu-Hung Lin, Rong-Sen Yang, Kuan-Chin Wang, Dai-Hua Lu, Houng-Chi Liou, Yun Ma, Shao-Han Chang, Wen-Mei Fu
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2013/647189

Similar Items

Effect of water and ethanol extracts from Davallia formosana Hayata on osteogenic activity
by: Wu, Chia-Feng, et al.
Published: (2017)

Ameliorative effects of Davallia formosana on osteoporosis in ovariectomized rats
by: Tai-i Hung, et al.
Published: (2011)

Evaluation of the Antihyperuricemic Activity of Phytochemicals from Davallia formosana by Enzyme Assay and Hyperuricemic Mice Model
by: Chen-Yu Chen, et al.
Published: (2014-01-01)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
by: Guoju Hong, et al.
Published: (2017-01-01)

Magnolol Inhibits Osteoclast Differentiation via Suppression of RANKL Expression
by: Youn-Hwan Hwang, et al.
Published: (2018-07-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-κB Activation and CXCL10 Expression
by: Zheng-tao Lv, et al.
Published: (2018-01-01)

(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice.
by: Cheng-Hsiu Lin, et al.
Published: (2017-01-01)

Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.
by: Lijuan Hu, et al.
Published: (2010-01-01)

Emerging Therapeutic Activity of <i>Davallia formosana</i> on Prostate Cancer Cells through Coordinated Blockade of Lipogenesis and Androgen Receptor Expression
by: Po-Fan Hsieh, et al.
Published: (2020-04-01)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01)

Genipin Inhibits RANKL-Induced Osteoclast Differentiation Through Proteasome-Mediated Degradation of c-Fos Protein and Suppression of NF-κB Activation
by: Chang Hoon Lee, et al.
Published: (2014-01-01)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
by: Lin Zhou, et al.
Published: (2015-11-01)

Evaluation Efficacy and Molecular Mechanisms of (−)-epicatechin-3-O-β-D-allopyranoside fromDavallia Formosana on Glucose Homeostasis and Therapeutic Approach to Diabetes and Hyperlipidemia
by: Jian, Jia-Ying, et al.
Published: (2016)

Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
by: Yu Yuan, et al.
Published: (2020-03-01)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
by: Jeong-Mi Kim, et al.
Published: (2017-04-01)

L-caldesmon alters cell spreading and adhesion force in RANKL-induced osteoclasts
by: Chu-Lung Chan, et al.
Published: (2019-01-01)

Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts
by: P. Narducci, et al.
Published: (2010-03-01)

A study of NO signaling in osteoclasts through RANKL, LPS and estrogen
by: Hsu Chun-Chao, et al.
Published: (2007)

Natural Germacrane Sesquiterpenes Inhibit Osteoclast Formation, Bone Resorption, RANKL-Induced NF-κB Activation, and IκBα Degradation
by: Shengnan Qin, et al.
Published: (2015-11-01)

Water extract of Uncaria sinensis suppresses RANKL-induced bone loss by attenuating osteoclast differentiation and bone resorption
by: Hyunil Ha, et al.
Published: (2017-12-01)

Ciri anatomi stip bagi beberapa spesies Davallia (Davalliaceae) di Malaysia (Stipe anatomical characteristics in some Davallia (Davalliaceae) Species in Malaysia)
by: Noraini, T, et al.
Published: (2012)

Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling
by: Shangfu Li, et al.
Published: (2016-10-01)

The crusading expeditions of 1101-2
by: Mulinder, Alec C.
Published: (1996)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
by: Xinyue Liang, et al.
Published: (2021-07-01)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021-11-01)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
by: Zi’ang Hu, et al.
Published: (2018-05-01)

α-1 Antitrypsin Inhibits RANKL-induced Osteoclast Formation and Functions
by: Mohammad Ahsanul Akbar, et al.
Published: (2017-03-01)

Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
by: Eun Mi Go, et al.
Published: (2020-04-01)

The Bioactive Constituents of Davallia solida, Pteris ensiformis and Hedyotis biflora
by: Yung-Husan Chen, et al.
Published: (2008)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
by: Gui-Hua Quan, et al.
Published: (2015-12-01)

Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways.
by: Xiaojuan Li, et al.
Published: (2013-01-01)

Aqueous extract of Chrysanthemum morifolium Ramat. inhibits RANKL-induced osteoclast differentiation by suppressing the c-fos/NFATc1 pathway
by: Jang, H.-Y, et al.
Published: (2021)

Total flavonoids from celery suppresses RANKL-induced osteoclast differentiation and bone resorption function via attenuating NF-κB and p38 pathways in RAW264.7 cells
by: Lujuan Jia, et al.
Published: (2020-06-01)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
by: Hyung Joon Kim, et al.
Published: (2019-03-01)

Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
by: Asiri R Wijenayaka, et al.
Published: (2011-01-01)

TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation
by: Aseel Marahleh, et al.
Published: (2019-12-01)

(−)-Epicatechin-3-O-β-d-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
by: Chun-Ching Shih, et al.
Published: (2015-10-01)

In vitro culture and somatic embryogenesis of Davallia mariesii Moore ex Bak
by: Yung-Ting Tsai, et al.
Published: (2009)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
by: Gyeong Do Park, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_r49cbd7r5ej7o585l6krmnroor